ecancermedicalscience

Erratum

Erratum: RENATA study—Latin American prospective experience: clinical outcome of patients treated with palbociclib in hormone receptor-positive metastatic breast cancer—real-world use

7 Aug 2020
Fernando Petracci, Gonzalo Gomez Abuin, Alejandra Pini, Matías Chacón

On page 3, the number 72.5 in the following sentence replaces the number 37.5 which was incorrect:

'The Overall CB was 82.5%, higher in first line than in second line, 85.9% and 62.5%, respectively. The ORR in first line were: 4.7% CR, 40.6% PR and 40.6% SD. In second line the ORR were: 25% PR, 37.5% SD and no CR.'

Related Articles

Abeir El-Mogassabi, Heithum Saleh Baiu, Nadin Omer Hassan, Enas Mohamed Salem, Lugien Elshakmak, Khalil A K Tamoos, Mohammed Zidan, Asma Rajab Ben Rashid, Ala Elhoudiri, Sama Elmehdawi, Dania Shareia
Md Foorquan Hashmi, Fiza Khan, Elen Baloyan, Liana Safaryan, Davit Zohrabyan, Gevorg Tamamyan, Samvel Bardakhchyan
Oluwafemi E Adesina, Oluwadamilare Akingbade, Emmanuel O Adesuyi, Yetunde Tola, Ooreofe Bolanle Adeyemi, Tosin Akintunde, Stephan Osei, Julius Maitanmi, Deborah T Esan
Gabriel Berlingieri Polho, Leticia Kimie Murazawa, Vinicius Vitor Oliveira, Victor Rocha Pinheiro, Diana del Cisne Pineda Labanda, Yumi Ricucci Shinkado, Romualdo Barroso-Sousa, Luciana Rodrigues Carvalho Barros, Laura Testa, Renata Colombo Bonadio
Tooba Ali, Nasir Ali, Syed Aun Hasan, Nawazish Zehra, Laraib Khan, Maham Khan, Mariam Hina, Bilal Ahmed, Fabiha Shakeel, Ahmed Nadeem Abbasi, Bilal Mazhar Qureshi, Asim Hafiz, Maria Tariq, Sehrish Abrar